Target intelligence / Profile preview

LysM and putative peptidoglycan-binding domain-containing protein 3 (LYSMD3)

Target
LYSMD3
Molecular classification
Other (type II integral membrane protein, LysM domain family)
01

Overview

LysM and putative peptidoglycan-binding domain-containing protein 3 (LYSMD3) is an evolutionarily conserved type II integral membrane protein that contains a lysin motif (LysM) domain, which is commonly associated with peptidoglycan binding[1][4]. In human and mouse cells, LYSMD3 is localized primarily to the Golgi apparatus and is essential for Golgi structural integrity[4][6]. Although its LysM domain suggests a potential role in innate immune functions or recognition of bacterial cell wall components, genetic knockout studies in mice have not established a clear in vivo physiological function for LYSMD3 and no deficiencies in immune response, inflammation, or intestinal microbiome were observed with its loss[1][2]. Orthologs exist across multiple species, highlighting evolutionary conservation, but no direct link to human disease or actionable therapeutic targeting is currently known[1][4].

Other names
LysM domain containing 3FLJ13542LYSMD3lysM and putative peptidoglycan-binding domain-containing protein 3
02

Biological functions

Golgi structural integritypeptidoglycan bindingGolgi organization
03

Disease associations

Other (no strong evidence for roles in specific diseases; associated but not causative in Usher syndrome type IIC)

Beyond the preview

Go deeper on LysM and putative peptidoglycan-binding domain-containing protein 3 (LYSMD3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LysM and putative peptidoglycan-binding domain-containing protein 3 (LYSMD3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call